References
1. Tsakok T, Marrs T, Mohsin M, et al. Does atopic dermatitis cause food
allergy? A systematic review. J Allergy Clin Immunol 2016; 137:
1071-1078. 2016/02/22. DOI: 10.1016/j.jaci.2015.10.049.
2. Lack G. Update on risk factors for food allergy. J Allergy Clin
Immunol 2012; 129: 1187-1197. DOI: 10.1016/j.jaci.2012.02.036.
3. Du Toit G, Roberts G, Sayre PH, et al. Randomized trial of peanut
consumption in infants at risk for peanut allergy. N Engl J Med2015; 372: 803-813. 2015/02/24. DOI: 10.1056/NEJMoa1414850.
4. Natsume O, Kabashima S, Nakazato J, et al. Two-step egg introduction
for prevention of egg allergy in high-risk infants with eczema (PETIT):
a randomised, double-blind, placebo-controlled trial. Lancet2017; 389: 276-286. 2016/12/13. DOI: 10.1016/s0140-6736(16)31418-0.
5. Nishimura T, Fukazawa M, Fukuoka K, et al. Early introduction of very
small amounts of multiple foods to infants: A randomized trial.Allergol Int 2022; 71: 345-353. 2022/04/04. DOI:
10.1016/j.alit.2022.03.001.
6. Miyaji Y, Yang L, Yamamoto-Hanada K, et al. Earlier aggressive
treatment to shorten the duration of eczema in infants resulted in fewer
food allergies at 2 years of age. J Allergy Clin Immunol Pract2020; 8: 1721-1724.e1726. 2019/12/11. DOI: 10.1016/j.jaip.2019.11.036.
7. Yamamoto-Hanada K, Kobayashi T, Mikami M, et al. Enhanced early skin
treatment for atopic dermatitis in infants reduces food allergy. J
Allergy Clin Immunol 2023; 152: 126-135. 2023/03/25. DOI:
10.1016/j.jaci.2023.03.008.
8. Bartnikas LM, Gurish MF, Burton OT, et al. Epicutaneous sensitization
results in IgE-dependent intestinal mast cell expansion and food-induced
anaphylaxis. J Allergy Clin Immunol 2013; 131: 451-460.e451-456.
2013/02/05. DOI: 10.1016/j.jaci.2012.11.032.
9. Brandt EB, Strait RT, Hershko D, et al. Mast cells are required for
experimental oral allergen-induced diarrhea. J Clin Invest 2003;
112: 1666-1677. 2003/12/09. DOI: 10.1172/jci19785.
10. Osterfeld H, Ahrens R, Strait R, et al. Differential roles for the
IL-9/IL-9 receptor alpha-chain pathway in systemic and oral
antigen-induced anaphylaxis. J Allergy Clin Immunol 2010; 125:
469-476.e462. 2010/02/18. DOI: 10.1016/j.jaci.2009.09.054.
11. Leyva-Castillo JM, Galand C, Kam C, et al. Mechanical Skin Injury
Promotes Food Anaphylaxis by Driving Intestinal Mast Cell Expansion.Immunity 2019; 50: 1262-1275.e1264. 20190423. DOI:
10.1016/j.immuni.2019.03.023.
12. Olivera A, Beaven MA and Metcalfe DD. Mast cells signal their
importance in health and disease. J Allergy Clin Immunol 2018;
142: 381-393. 20180215. DOI: 10.1016/j.jaci.2018.01.034.
13. Kawasaki A, Ito N, Murai H, et al. Skin inflammation exacerbates
food allergy symptoms in epicutaneously sensitized mice. Allergy2018; 73: 1313-1321. 20180131. DOI: 10.1111/all.13404.
14. Yoshida K, Kubo A, Fujita H, et al. Distinct behavior of human
Langerhans cells and inflammatory dendritic epidermal cells at tight
junctions in patients with atopic dermatitis. J Allergy Clin
Immunol 2014; 134: 856-864. 2014/10/06. DOI:
10.1016/j.jaci.2014.08.001.
15. Lack G, Fox D, Northstone K, et al. Factors associated with the
development of peanut allergy in childhood. N Engl J Med 2003;
348: 977-985. 20030310. DOI: 10.1056/NEJMoa013536.
16. Fox AT, Sasieni P, du Toit G, et al. Household peanut consumption as
a risk factor for the development of peanut allergy. J Allergy
Clin Immunol 2009; 123: 417-423. 2009/02/11. DOI:
10.1016/j.jaci.2008.12.014.
17. Brough HA, Simpson A, Makinson K, et al. Peanut allergy: effect of
environmental peanut exposure in children with filaggrin
loss-of-function mutations. J Allergy Clin Immunol 2014; 134:
867-875.e861. DOI: 10.1016/j.jaci.2014.08.011.
18. Fukutomi Y, Taniguchi M, Nakamura H, et al. Epidemiological link
between wheat allergy and exposure to hydrolyzed wheat protein in facial
soap. Allergy 2014; 69: 1405-1411. 20140816. DOI:
10.1111/all.12481.
19. Boussault P, Léauté-Labrèze C, Saubusse E, et al. Oat sensitization
in children with atopic dermatitis: prevalence, risks and associated
factors. Allergy 2007; 62: 1251-1256. DOI:
10.1111/j.1398-9995.2007.01527.x.
20. Kruse L, Lor J, Yousif R, et al. Coconut allergy: Characteristics of
reactions and diagnostic predictors in a pediatric tertiary care center.Ann Allergy Asthma Immunol 2021; 126: 562-568.e561. 20210204.
DOI: 10.1016/j.anai.2021.01.027.
21. Williams MR, Nakatsuji T, Sanford JA, et al. Staphylococcus aureus
Induces Increased Serine Protease Activity in Keratinocytes. J
Invest Dermatol 2017; 137: 377-384. 20161017. DOI:
10.1016/j.jid.2016.10.008.
22. Nakatsuji T, Chen TH, Two AM, et al. Staphylococcus aureus Exploits
Epidermal Barrier Defects in Atopic Dermatitis to Trigger Cytokine
Expression. J Invest Dermatol 2016; 136: 2192-2200. 20160702.
DOI: 10.1016/j.jid.2016.05.127.
23. Nakatsuji T, Chen TH, Narala S, et al. Antimicrobials from human
skin commensal bacteria protect against Staphylococcus aureus and are
deficient in atopic dermatitis. Sci Transl Med 2017; 9. DOI:
10.1126/scitranslmed.aah4680.
24. Meylan P, Lang C, Mermoud S, et al. Skin Colonization by
Staphylococcus aureus Precedes the Clinical Diagnosis of Atopic
Dermatitis in Infancy. J Invest Dermatol 2017; 137: 2497-2504.
20170824. DOI: 10.1016/j.jid.2017.07.834.
25. Kennedy EA, Connolly J, Hourihane JO, et al. Skin microbiome before
development of atopic dermatitis: Early colonization with commensal
staphylococci at 2 months is associated with a lower risk of atopic
dermatitis at 1 year. J Allergy Clin Immunol 2017; 139: 166-172.
20160905. DOI: 10.1016/j.jaci.2016.07.029.
26. Leung DYM, Calatroni A, Zaramela LS, et al. The nonlesional skin
surface distinguishes atopic dermatitis with food allergy as a unique
endotype. Sci Transl Med 2019; 11. DOI:
10.1126/scitranslmed.aav2685.
27. Tsilochristou O, du Toit G, Sayre PH, et al. Association of
Staphylococcus aureus colonization with food allergy occurs
independently of eczema severity. J Allergy Clin Immunol 2019;
144: 494-503. 20190531. DOI: 10.1016/j.jaci.2019.04.025.
28. Horimukai K, Morita K, Narita M, et al. Application of moisturizer
to neonates prevents development of atopic dermatitis. J Allergy
Clin Immunol 2014; 134: 824-830.e826. DOI: 10.1016/j.jaci.2014.07.060.
29. Simpson EL, Chalmers JR, Hanifin JM, et al. Emollient enhancement of
the skin barrier from birth offers effective atopic dermatitis
prevention. J Allergy Clin Immunol 2014; 134: 818-823. DOI:
10.1016/j.jaci.2014.08.005.
30. Skjerven HO, Rehbinder EM, Vettukattil R, et al. Skin emollient and
early complementary feeding to prevent infant atopic dermatitis
(PreventADALL): a factorial, multicentre, cluster-randomised trial.Lancet 2020; 395: 951-961. DOI: 10.1016/S0140-6736(19)32983-6.
31. Chalmers JR, Haines RH, Bradshaw LE, et al. Daily emollient during
infancy for prevention of eczema: the BEEP randomised controlled trial.Lancet 2020; 395: 962-972. DOI: 10.1016/S0140-6736(19)32984-8.
32. Skjerven HO, Lie A, Vettukattil R, et al. Early food intervention
and skin emollients to prevent food allergy in young children
(PreventADALL): a factorial, multicentre, cluster-randomised trial.Lancet 2022; 399: 2398-2411. 2022/06/27. DOI:
10.1016/s0140-6736(22)00687-0.
33. Lowe AJ, Su JC, Allen KJ, et al. A randomized trial of a barrier
lipid replacement strategy for the prevention of atopic dermatitis and
allergic sensitization: the PEBBLES pilot study. BMC Dermatol2018; 178: e19-e21. https://doi.org/10.1111/bjd.15747. DOI:
https://doi.org/10.1111/bjd.15747.
34. Lowe A, Su J, Tang M, et al. PEBBLES study protocol: a randomised
controlled trial to prevent atopic dermatitis, food allergy and
sensitisation in infants with a family history of allergic disease using
a skin barrier improvement strategy. BMJ Open 2019; 9: e024594.
2019/03/15. DOI: 10.1136/bmjopen-2018-024594.
35. C NC, Lad D, Nico C, et al. Early initiation of short-term emollient
use for the prevention of atopic dermatitis in high-risk infants-The
STOP-AD randomised controlled trial. Allergy 2023; 78: 984-994.
2022/08/24. DOI: 10.1111/all.15491.
36. Kelleher MM, Cro S, Van Vogt E, et al. Skincare interventions in
infants for preventing eczema and food allergy: A cochrane systematic
review and individual participant data meta-analysis. Clin Exp
Allergy 2021; 51: 402-418. 20210225. DOI: 10.1111/cea.13847.
37. Zhong Y, Samuel M, van Bever H, et al. Emollients in infancy to
prevent atopic dermatitis: A systematic review and meta-analysis.Allergy 2022; 77: 1685-1699. 20211012. DOI: 10.1111/all.15116.
38. Dissanayake E, Tani Y, Nagai K, et al. Skin Care and Synbiotics for
Prevention of Atopic Dermatitis or Food Allergy in Newborn Infants: A 2
× 2 Factorial, Randomized, Non-Treatment Controlled Trial. Int
Arch Allergy Immunol 2019; 180: 202-211. 2019/08/09. DOI:
10.1159/000501636.
39. Danby SG, Andrew PV, Taylor RN, et al. Different types of emollient
cream exhibit diverse physiological effects on the skin barrier in
adults with atopic dermatitis. Clin Exp Dermatol 2022; 47:
1154-1164. 2022/02/16. DOI: 10.1111/ced.15141.
40. Bradshaw LE, Wyatt LA, Brown SJ, et al. Emollients for prevention of
atopic dermatitis: 5-year findings from the BEEP randomized trial.Allergy 2022 20221019. DOI: 10.1111/all.15555.
41. Inuzuka Y, Yamamoto-Hanada K, Kobayashi T, et al. Prevention of
Atopic Dermatitis in High-risk Neonates via Different Types of
Moisturizer Application: a Randomized, Blinded, Parallel, Three-group,
Phase II Trial (PAF study). J Eur Acad Dermatol Venereol 2023
2023/07/21. DOI: 10.1111/jdv.19375.
42. Zettersten EM, Ghadially R, Feingold KR, et al. Optimal ratios of
topical stratum corneum lipids improve barrier recovery in
chronologically aged skin. J Am Acad Dermatol 1997; 37: 403-408.
1997/10/06. DOI: 10.1016/s0190-9622(97)70140-3.
43. Danby SG, Andrew PV, Kay LJ, et al. Enhancement of stratum corneum
lipid structure improves skin barrier function and protects against
irritation in adults with dry, eczema-prone skin. Br J Dermatol2022; 186: 875-886. 2021/12/19. DOI: 10.1111/bjd.20955.
44. Sindher S, Alkotob SS, Shojinaga MN, et al. Increases in plasma
IgG4/IgE with trilipid vs paraffin/petrolatum-based emollients for dry
skin/eczema. Pediatr Allergy Immunol 2020; 31: 699-703.
2020/05/07. DOI: 10.1111/pai.13253.
45. Marrs T, Perkin MR, Logan K, et al. Bathing frequency is associated
with skin barrier dysfunction and atopic dermatitis at three months of
age. J Allergy Clin Immunol Pract 2020; 8: 2820-2822. 2020/04/30.
DOI: 10.1016/j.jaip.2020.04.043.
46. Perkin MR, Logan K, Marrs T, et al. Association of frequent
moisturizer use in early infancy with the development of food allergy.J Allergy Clin Immunol 2021; 147: 967-976.e961. DOI:
10.1016/j.jaci.2020.10.044.
47. Kelleher MM, Phillips R, Brown SJ, et al. Skin care interventions in
infants for preventing eczema and food allergy. Cochrane Database
Syst Rev 2022; 11: Cd013534. 2022/11/15. DOI:
10.1002/14651858.CD013534.pub3.
48. Schneider L, Hanifin J, Boguniewicz M, et al. Study of the Atopic
March: Development of Atopic Comorbidities. Pediatr Dermatol2016; 33: 388-398. 2016/06/09. DOI: 10.1111/pde.12867.
49. Wollenberg A and Ehmann LM. Long Term Treatment Concepts and
Proactive Therapy for Atopic Eczema. ad 2012; 24: 253-260. DOI:
10.5021/ad.2012.24.3.253.
50. Miyaji Y, Yamamoto‐Hanada K, Fukuie T, et al. Risk factors of
admission in school children with severe atopic dermatitis. The
Journal of Dermatology 2022. DOI: 10.1111/1346-8138.16612.
51. Wollenberg A, Kinberger M, Arents B, et al. European guideline
(EuroGuiDerm) on atopic eczema – part II: non-systemic treatments and
treatment recommendations for special AE patient populations.Journal of the European Academy of Dermatology and Venereology2022; 36: 1904-1926. DOI: https://doi.org/10.1111/jdv.18429.
52. Saeki H, Ohya Y, Furuta J, et al. English Version of Clinical
Practice Guidelines for the Management of Atopic Dermatitis 2021.J Dermatol 2022; 49: e315-e375. 2022/08/23. DOI:
10.1111/1346-8138.16527.
53. Fukuie T, Hirakawa S, Narita M, et al. Potential preventive effects
of proactive therapy on sensitization in moderate to severe childhood
atopic dermatitis: A randomized, investigator-blinded, controlled study.J Dermatol 2016; 43: 1283-1292. DOI: 10.1111/1346-8138.13408.
54. Murashkin NN, Namazova-Baranova LS, Makarova SG, et al.
Observational study of pimecrolimus 1% cream for prevention of
transcutaneous sensitization in children with atopic dermatitis during
their first year of life. Front Pediatr 2023; 11: 1102354.
2023/05/14. DOI: 10.3389/fped.2023.1102354.
55. Yamamoto-Hanada K, Kobayashi T, Mikami M, et al. Enhanced early skin
treatment for atopic dermatitis in infants reduces food allergy.Journal of Allergy and Clinical Immunology 2023; 152: 126-135.
DOI: https://doi.org/10.1016/j.jaci.2023.03.008.
56. Yamamoto-Hanada K, Kobayashi T, Williams HC, et al. Early aggressive
intervention for infantile atopic dermatitis to prevent development of
food allergy: a multicenter, investigator-blinded, randomized, parallel
group controlled trial (PACI Study)-protocol for a randomized controlled
trial. Clin Transl Allergy 2018; 8: 47. DOI:
10.1186/s13601-018-0233-8.
57. Natsume O, Kabashima S, Nakazato J, et al. Two-step egg introduction
for prevention of egg allergy in high-risk infants with eczema (PETIT):
a randomised, double-blind, placebo-controlled trial. The Lancet2017; 389: 276-286. DOI: 10.1016/s0140-6736(16)31418-0.
58. Logan K, Bahnson HT, Ylescupidez A, et al. Early introduction of
peanut reduces peanut allergy across risk groups in pooled and causal
inference analyses. Allergy 2023; 78: 1307-1318. 20221211. DOI:
10.1111/all.15597.
59. Lack G. Epidemiologic risks for food allergy. J Allergy Clin
Immunol 2008; 121: 1331-1336. DOI: 10.1016/j.jaci.2008.04.032.
60. Yamamoto-Hanada K and Ohya Y. Skin and oral intervention for food
allergy prevention based on the dual allergen exposure hypothesis.Clin Exp Pediatr 2023 2023/06/16. DOI: 10.3345/cep.2023.00045.